CureCast Episode 32: Interview with Dr. Stephen Strittmater about ReNetX

Kate, Matthew and Jason Stoffer (our new podcast host) have a conversation with Dr. Stephen Strittmatter, The Vincent Coates Professor of Neurology and Professor of Neuroscience at Yale School of Medicine. His discoveries over the last two decades of research led to the founding of ReNetX, who are applying that technology to discover if neurons can regrow in the chronic injury (in humans) by eliminating inhibitory growth factors. We discuss the pre-clinical research, the mechanistic activity and the challenges of translating a discovery to clinical relevance. Here are a few links to give you some background: Background and clinical trial info: https://www.renetx.com/technology.html Publications: https://www.renetx.com/publications.html Recent blog post from our Scientific Advisory Board Director, Sam Maddox: https://u2fp.org/get-educated/our-voice.html/article/2019/10/29/clinical-trial-enrolling-chronic-sci-renetx Let us know what you think at curecast@u2fp.org If you want to help us feed the movement we need to cure paralysis from SCI you can donate to u2fp here. Thanks for listening.